vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and LendingClub Corp (LC). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $252.3M, roughly 1.1× LendingClub Corp). LendingClub Corp runs the higher net margin — 20.5% vs 0.7%, a 19.7% gap on every dollar of revenue. On growth, LendingClub Corp posted the faster year-over-year revenue change (15.9% vs -16.5%).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

LendingClub Corporation is an American financial services company headquartered in San Francisco, California. It was the first peer-to-peer lender to register its offerings as securities with the Securities and Exchange Commission (SEC), and to offer loan trading on a secondary market. At its height, LendingClub was the world's largest peer-to-peer lending platform. The company reported that $15.98 billion in loans had been originated through its platform up to December 31, 2015.

HCM vs LC — Head-to-Head

Bigger by revenue
HCM
HCM
1.1× larger
HCM
$270.8M
$252.3M
LC
Growing faster (revenue YoY)
LC
LC
+32.4% gap
LC
15.9%
-16.5%
HCM
Higher net margin
LC
LC
19.7% more per $
LC
20.5%
0.7%
HCM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HCM
HCM
LC
LC
Revenue
$270.8M
$252.3M
Net Profit
$2.0M
$51.6M
Gross Margin
37.7%
Operating Margin
-13.2%
Net Margin
0.7%
20.5%
Revenue YoY
-16.5%
15.9%
Net Profit YoY
-83.6%
341.0%
EPS (diluted)
$0.00
$0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
LC
LC
Q1 26
$252.3M
Q4 25
$270.8M
$266.5M
Q3 25
$266.2M
Q2 25
$277.7M
$248.4M
Q1 25
$324.5M
$217.7M
Q4 24
$217.2M
Q3 24
$201.9M
Q2 24
$305.7M
$187.2M
Net Profit
HCM
HCM
LC
LC
Q1 26
$51.6M
Q4 25
$2.0M
Q3 25
$44.3M
Q2 25
$455.0M
$38.2M
Q1 25
$11.9M
$11.7M
Q4 24
Q3 24
$14.5M
Q2 24
$25.8M
$14.9M
Gross Margin
HCM
HCM
LC
LC
Q1 26
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Operating Margin
HCM
HCM
LC
LC
Q1 26
Q4 25
-13.2%
18.8%
Q3 25
21.5%
Q2 25
-1.3%
21.7%
Q1 25
-5.0%
7.2%
Q4 24
5.1%
Q3 24
8.9%
Q2 24
-9.0%
10.4%
Net Margin
HCM
HCM
LC
LC
Q1 26
20.5%
Q4 25
0.7%
Q3 25
16.6%
Q2 25
163.8%
15.4%
Q1 25
3.7%
5.4%
Q4 24
Q3 24
7.2%
Q2 24
8.4%
8.0%
EPS (diluted)
HCM
HCM
LC
LC
Q1 26
$0.44
Q4 25
$0.00
$0.36
Q3 25
$0.37
Q2 25
$0.52
$0.33
Q1 25
$0.01
$0.10
Q4 24
$0.08
Q3 24
$0.13
Q2 24
$0.03
$0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
LC
LC
Cash + ST InvestmentsLiquidity on hand
$1.4B
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$1.5B
Total Assets
$1.8B
$11.9B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
LC
LC
Q1 26
Q4 25
$1.4B
Q3 25
Q2 25
$1.4B
Q1 25
$836.1M
Q4 24
Q3 24
Q2 24
$802.5M
Total Debt
HCM
HCM
LC
LC
Q1 26
Q4 25
$93.2M
$0
Q3 25
$0
Q2 25
$93.4M
$0
Q1 25
$82.8M
$0
Q4 24
$0
Q3 24
Q2 24
$82.1M
Stockholders' Equity
HCM
HCM
LC
LC
Q1 26
$1.5B
Q4 25
$1.2B
$1.5B
Q3 25
$1.5B
Q2 25
$1.2B
$1.4B
Q1 25
$759.9M
$1.4B
Q4 24
$1.3B
Q3 24
$1.3B
Q2 24
$740.1M
$1.3B
Total Assets
HCM
HCM
LC
LC
Q1 26
$11.9B
Q4 25
$1.8B
$11.6B
Q3 25
$11.1B
Q2 25
$1.8B
$10.8B
Q1 25
$1.3B
$10.5B
Q4 24
$10.6B
Q3 24
$11.0B
Q2 24
$1.3B
$9.6B
Debt / Equity
HCM
HCM
LC
LC
Q1 26
Q4 25
0.08×
0.00×
Q3 25
0.00×
Q2 25
0.08×
0.00×
Q1 25
0.11×
0.00×
Q4 24
0.00×
Q3 24
Q2 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
LC
LC
Operating Cash FlowLast quarter
$8.2M
Free Cash FlowOCF − Capex
$3.4M
FCF MarginFCF / Revenue
1.2%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
LC
LC
Q1 26
Q4 25
$8.2M
$-2.7B
Q3 25
$-770.8M
Q2 25
$-72.9M
$-713.1M
Q1 25
$40.3M
$-339.3M
Q4 24
$-2.6B
Q3 24
$-669.8M
Q2 24
$-39.8M
$-932.5M
Free Cash Flow
HCM
HCM
LC
LC
Q1 26
Q4 25
$3.4M
$-2.9B
Q3 25
$-791.8M
Q2 25
$-82.2M
$-803.8M
Q1 25
$32.5M
$-352.3M
Q4 24
$-2.7B
Q3 24
$-682.3M
Q2 24
$-49.9M
$-945.3M
FCF Margin
HCM
HCM
LC
LC
Q1 26
Q4 25
1.2%
-1076.0%
Q3 25
-297.4%
Q2 25
-29.6%
-323.5%
Q1 25
10.0%
-161.8%
Q4 24
-1237.8%
Q3 24
-338.0%
Q2 24
-16.3%
-504.9%
Capex Intensity
HCM
HCM
LC
LC
Q1 26
Q4 25
1.8%
52.7%
Q3 25
7.9%
Q2 25
3.3%
36.5%
Q1 25
2.4%
6.0%
Q4 24
25.0%
Q3 24
6.2%
Q2 24
3.3%
6.9%
Cash Conversion
HCM
HCM
LC
LC
Q1 26
Q4 25
4.21×
Q3 25
-17.41×
Q2 25
-0.16×
-18.68×
Q1 25
3.38×
-29.07×
Q4 24
Q3 24
-46.33×
Q2 24
-1.54×
-62.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons